Search filters

List of works by Emilio Esteban

A Prospective Observational Study for Assessment and Outcome Association of Circulating Endothelial Cells in Clear Cell Renal Cell Carcinoma Patients Who Show Initial Benefit from First-line Treatment. The CIRCLES (CIRCuLating Endothelial cellS) Stu

scientific article

ASTRIS, a large real-world study to evaluate the efficacy of osimertinib in epidermal growth factor receptor T790M mutation-positive non-small cell lung cancer patients: Clinical characteristics and genotyping methods in a Spanish cohort

scientific article published on 13 January 2020

Abdominal ultrasonography versus abdominal CT in the follow-up of testicular germ cell tumors

scientific article published on 8 June 2011

Abstract CT043: Outcomes among patients (pts) with metastatic nonsquamous NSCLC with liver metastases or brain metastases treated with pembrolizumab (pembro) plus pemetrexed-platinum: Results from the KEYNOTE-189 study

scholarly article

Activity of weekly irinotecan (CPT-11) in patients with advanced non-small cell lung cancer pretreated with platinum and taxanes ⬇️

scientific article published on November 1, 2003

Assessing Acute Diarrhea from sulfate in drinking water

scholarly article published in September 2001

Biochemical markers of bone turnover and clinical outcome in patients with renal cell and bladder carcinoma with bone metastases following treatment with zoledronic acid: The TUGAMO study.

scientific article published on 25 June 2013

CT scan prior to radiotherapy in unresectable, locally advanced, non-small cell carcinoma of the lung: is it always necessary?

scientific article published on 18 April 2016

Cabazitaxel for metastatic castration-resistant prostate cancer: safety data from the Spanish expanded access program.

scientific article

Chemotherapy-associated anemia in patients with lung cancer: an epidemiological, retrospective and multicenter study.

scientific article published on January 2015

Cisplatin plus gemcitabine with or without vinorelbine as induction chemotherapy prior to radical locoregional treatment for patients with stage III non-small-cell lung cancer (NSCLC): results of a prospective randomized study

scientific article published on 27 October 2006

Combination chemotherapy with cisplatin and 5-fluorouracil 5-day infusion in the therapy of advanced gastric cancer: A Phase II trial ⬇️

scientific article published on November 1, 1991

Combination of docetaxel, epirubicin and vinorelbine administered every 2 weeks as first-line therapy in patients with metastatic breast cancer: a dose-finding study.

scientific article published on August 2003

Consensus Recommendations from the Spanish Germ Cell Cancer Group on the Use of High-dose Chemotherapy in Germ Cell Cancer.

scientific article published on 18 July 2016

Controversies in the treatment of invasive urothelial carcinoma: a case report and review of the literature.

scientific article

Dacarbazine in advanced squamous cell carcinoma of the head and neck ⬇️

scientific article published on January 1, 1991

Deep sequencing reveals microRNAs predictive of antiangiogenic drug response

scientific article published on 07 July 2016

Dovitinib versus sorafenib for third-line targeted treatment of patients with metastatic renal cell carcinoma: an open-label, randomised phase 3 trial.

scientific article published on 17 February 2014

Epidermal growth factor receptor and epididymis invasion as prognostic biomarkers in clinical stage I testicular germ cell tumours

scientific article published on 20 March 2017

Erlotinib as maintenance treatment in advanced non-small-cell lung cancer: a multicentre, randomised, placebo-controlled phase 3 study.

scientific article published on 20 May 2010

Experience in the use of sunitinib given as a single agent in metastatic chemoresistant and castration-resistant prostate cancer patients

scientific article

Experience with Sunitinib in metastatic renal cell carcinoma (mRCC) patients: pooled analysis from 3 Spanish observational prospective studies.

scientific article published on 24 May 2017

Expert Recommendations for First-Line Management of Metastatic Renal Cell Carcinoma in Special Subpopulations.

scientific article

Functional PTGS2 polymorphism-based models as novel predictive markers in metastatic renal cell carcinoma patients receiving first-line sunitinib

scientific article published on 24 January 2017

Gemcitabine and oxaliplatin combination: a multicenter phase II trial in unfit patients with locally advanced or metastatic urothelial cancer

scientific article published on 01 August 2007

Gemcitabine and vinorelbine (GV) versus cisplatin, gemcitabine and vinorelbine (CGV) as first-line treatment in advanced non small cell lung cancer: results of a prospective randomized phase II study

scientific article

HIF pathway and c-Myc as biomarkers for response to sunitinib in metastatic clear-cell renal cell carcinoma.

scientific article published on 20 September 2017

High-dose mitoxantrone and cyclophosphamide without stem cell support in patients with high-risk and advanced breast carcinoma: a Phase II multicentric trial.

scientific article

IL8 polymorphisms and overall survival in pazopanib- or sunitinib-treated patients with renal cell carcinoma

scientific article

INMUNOSUN-SOGUG trial: A prospective phase II study to assess the efficacy and safety of sunitinib as second-line (2L) treatment in patients (pts) with metastatic renal cell cancer (RCC) who received immunotherapy-based combination upfront.

scientific article published in 2020

Identification of tissue microRNAs predictive of sunitinib activity in patients with metastatic renal cell carcinoma

scientific article published on 24 January 2014

Impact of the incorporation of tyrosine kinase inhibitor agents on the treatment of patients with a diagnosis of advanced renal cell carcinoma: study based on experience at the Hospital Universitario Central de Asturias.

scientific article published on August 2010

Impact on clinical practice of the implementation of guidelines for the toxicity management of targeted therapies in kidney cancer. The protect-2 study

scientific article published on 22 February 2016

Inhaled IL-2 induces systemic immunomodulation in patients with renal cell carcinoma and lung metastasis

scientific article published on 01 July 2008

Irinotecan in the treatment of advanced colorectal cancer in patients pretreated with Fluorouracil-based chemotherapy: a study to determine recommendable therapeutic dosage

scientific article published in April 2003

Management of the adverse events of afatinib: a consensus of the recommendations of the Spanish expert panel

scientific article

Novel potential predictive markers of sunitinib outcomes in long-term responders versus primary refractory patients with metastatic clear-cell renal cell carcinoma.

scientific article published on 23 March 2017

Observational Prospective Study to Determine the Evolution of the Symptomatic Profile of Metastatic Non-Small Cell Lung Cancer (NSCLC) Patients and Its Relation to the Control of the Disease

scientific article published on 08 April 2019

PTEN expression and mutations in TSC1, TSC2 and MTOR are associated with response to rapalogs in patients with renal cell carcinoma

scientific article published on 09 August 2019

Patient-reported outcomes following pembrolizumab or placebo plus pemetrexed and platinum in patients with previously untreated, metastatic, non-squamous non-small-cell lung cancer (KEYNOTE-189): a multicentre, double-blind, randomised, placebo-cont

scientific article published on 06 February 2020

Pazopanib as Second-line Antiangiogenic Treatment in Metastatic Renal Cell Carcinoma After Tyrosine Kinase Inhibitor (TKI) Failure: A Phase 2 Trial Exploring Immune-related Biomarkers for Testing in the Post-immunotherapy/TKI Era

scientific article published on 30 August 2019

Pegylated liposomal doxorubicin and gemcitabine in a fixed dose rate infusion for the treatment of patients with poor prognosis of recurrent ovarian cancer: a phase Ib study

scientific article published on 01 April 2011

Pembrolizumab plus Chemotherapy in Metastatic Non-Small-Cell Lung Cancer.

scientific article published on 16 April 2018

Pemetrexed in first-line treatment of non-small cell lung cancer.

scientific article published on 06 March 2009

Phase I clinical trial of fixed-dose rate infusional gemcitabine and dacarbazine in the treatment of advanced soft tissue sarcoma, with assessment of gemcitabine triphosphate accumulation.

scientific article published on November 2004

Phase I/II study of gemcitabine and vinorelbine plus cisplatin in non-small cell lung cancer

scientific article

Phase I/II study of gemcitabine plus vinorelbine in non-small cell lung cancer

scientific article

Phase I/II trial of doxorubicin and fixed dose-rate infusion gemcitabine in advanced soft tissue sarcomas: a GEIS study.

scientific article published on 23 May 2006

Phase II study of carboplatin and 1-h intravenous etoposide and paclitaxel in a novel sequence as first-line treatment of patients with small-cell lung cancer.

scientific article

Phase II study of mitomycin C plus 5-fluorouracil in patients with refractory ovarian cancer ⬇️

scientific article published on 01 January 1994

Predictive factors for response to treatment in patients with advanced renal cell carcinoma

scientific article published on 27 May 2012

Prevalence of EGFR mutations in newly diagnosed locally advanced or metastatic non-small cell lung cancer Spanish patients and its association with histological subtypes and clinical features: The Spanish REASON study.

scientific article published on 9 March 2015

Prognostic factors in patients with advanced renal cell carcinoma.

scientific article

Prospective randomised phase II study of docetaxel versus paclitaxel administered weekly in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy.

scientific article published in November 2003

Prospective study assessing hypoxia-related proteins as markers for the outcome of treatment with sunitinib in advanced clear-cell renal cell carcinoma.

scientific article published on 20 June 2013

Pulmonary toxicity in patients treated with gemcitabine plus vinorelbine or docetaxel for advanced non-small cell lung cancer: outcome data on a randomized phase II study

scientific article

Quality of life and supportive care for patients with metastatic renal cell carcinoma.

scientific article published on September 2012

Radium-223 international early access program: results from the Spanish subset.

scientific article published on 13 December 2017

Randomised phase II study comparing alternating cycles of sunitinib and everolimus versus standard sequential administration in first-line metastatic renal carcinoma (SUNRISES study)

scientific article published on 12 July 2020

Randomized phase III trial of temsirolimus versus sorafenib as second-line therapy after sunitinib in patients with metastatic renal cell carcinoma.

scientific article

Recent advances in genitourinary tumors: A review focused on biology and systemic treatment

scientific article

Recommendations for the optimal management of early and advanced urothelial carcinoma

scientific article

Recommendations from the Spanish Oncology Genitourinary Group for the treatment of metastatic renal cancer

scientific article published on March 2009

Results of the FLAC European Database of Metastatic Castration-Resistant Prostate Cancer Patients Treated With Docetaxel, Cabazitaxel, and Androgen Receptor-Targeted Agents.

scientific article published on 23 February 2018

Simultaneous determination of gemcitabine di- and triphosphate in human blood mononuclear and cancer cells by RP-HPLC and UV detection.

scientific article published on 24 May 2006

Single nucleotide polymorphism associations with response and toxic effects in patients with advanced renal-cell carcinoma treated with first-line sunitinib: a multicentre, observational, prospective study

article

Sunitinib rechallenge in advanced renal cell carcinoma: outcomes of a multicenter retrospective study

scientific article published on 31 July 2019

The Wide Experience of the Sequential Therapy for Patients with Metastatic Renal Cell Carcinoma

scientific article published on November 2016

The trans-activating C-type retroviruses share a distinct epitope(s) that induces antibodies in certain infected hosts

scientific article published on September 1, 1991

Update from the Spanish Oncology Genitourinary Group on the treatment of advanced renal cell carcinoma: focus on special populations

scientific article published on August 2010

Updated Analysis From KEYNOTE-189: Pembrolizumab or Placebo Plus Pemetrexed and Platinum for Previously Untreated Metastatic Nonsquamous Non-Small-Cell Lung Cancer

scientific article published on 09 March 2020

Updated recommendations from the Spanish Oncology Genitourinary Group on the treatment of advanced renal cell carcinoma

scientific article published on August 2010

Usefulness of bone turnover markers as predictors of mortality risk, disease progression and skeletal-related events appearance in patients with prostate cancer with bone metastases following treatment with zoledronic acid: TUGAMO study

scientific article published on 30 May 2013

Paulina is supported by:

About Paulina

Help